Table 3 Application of chemotherapeutic drugs and lipiodol in TACE
Group | Chi-square test (P value) | |||
|---|---|---|---|---|
TACE (N = 133) | TACE + dexamethasone (N = 122) | Pearson chi-square | Fisher’s exact test | |
Intraoperative chemotherapeutic agents | ||||
Lobaplatin | ||||
Count (%) | 68 (51.1%) | 63 (51.6%) | 0.935 | 1.000 |
Epirubicin | ||||
Count (%) | 65 (48.9%) | 59 (48.4%) | ||
Intraoperative lipiodol dose | ||||
< 5 ml | ||||
Count (%) | 41 (30.8%) | 39 (32.0%) | 0.897 | |
5–10 ml | ||||
Count (%) | 55 (41.4%) | 47 (38.5%) | ||
10 ml | ||||
Count (%) | 37 (27.8%) | 36 (29.5%) | ||